It's all on Santa's shoulders. 2024 has been a stellar year for the S&P 500 SPX - but no thanks to December, which is in danger of bucking its history as one of the best months of the year for stocks.

The gains come despite the dollar hovering near the year's high against a basket of foreign currencies on the U.S. Dollar Index. A stronger greenback makes dollar-denominated energy contracts more ...

My recently widowed mother asked me if I think we should get a life-insurance policy (it was fresh on her mind as we handled everything for Dad). She is 72, in great health, and independently wealthy.

The most and least popular asset classes among big investors emerge from the highly regarded monthly Bank of America Securities Global Fund Manager Survey, which typically talks to about 200 asset ...

Give each child an equal amount and allow them to make their own mistakes. If you don't trust your daughter to spend the money wisely, have a separate conversation with each child about their needs, ...

My relative says the parents could be held liable if he gets into a car accident, as he is their legal dependent. I say they couldn't be, because he's an adult, it's his car and he's on the ...

The Fed on Monday said it planned to overhaul the stress-test regime for banks and planned to seek public comment on planned changes. Lower valuations are usually the silver lining of a slumping ...

The carrier had briefly halted all flights on a high-pressure day for holiday travel. The Japanese company urged Biden to reflect on the steps it has taken to address national-security concerns. One ...

Trade groups representing the largest U.S. banks on Tuesday filed suit in federal court to force more transparency in the U.S. Federal Reserve's bank stress tests imposed after the 2008 global ...

As some financial advisers become more technology-driven and as low-cost robo-advisers gain more traction, financial planner Casey Weade is taking a different approach to retirement advice - one that ...

Treasury yields continued to climb on Tuesday, with the 10-year note pushing above the closely watched 4.60% level in recent trading during a holiday-shortened Christmas Eve session. -- The yield on ...

Achilles Therapeutics has sold certain technology assets to drug giant AstraZeneca for $12 million following a review of strategic alternatives by the clinical-stage biopharmaceutical company.